Beta
Semaglutide
medicationGLP-1 receptor agonist (brand names: Ozempic, Wegovy). Used for type 2 diabetes and weight management. Weekly injection.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Semaglutide to your stack to report effects
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Once-Daily Oral Semaglutide With, Without, or in Combination With Metformin in Patients With Type 2 Diabetes
Ahrén B, Masmiquelle C, Freyche S, et al.
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.
Wilding JPH, Batterham RL, Calanna S, et al.
Semaglutide for the treatment of overweight and obesity: A review
Wilding JPH, et al.
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Semaglutide to your stack to report effects
Compounded Semaglutide and Tirzepatide Products Use Unique Formulations but Efficacy and Safety Largely Unknown.
Hussain Z, Khan JA
No reports yet
Be the first to report this effect and help the community.
Add Semaglutide to your stack to report effects
Compounded Semaglutide and Tirzepatide Products Use Unique Formulations but Efficacy and Safety Largely Unknown.
Hussain Z, Khan JA
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Metabolic disorder characterized by high blood sugar
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Once-Daily Oral Semaglutide With, Without, or in Combination With Metformin in Patients With Type 2 Diabetes
Ahrén B, Masmiquelle C, Freyche S, et al.
Research (4 studies)
Semaglutide for the treatment of overweight and obesity: A review
Wilding JPH, et al.
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.
Wilding JPH, Batterham RL, Calanna S, et al.
Compounded Semaglutide and Tirzepatide Products Use Unique Formulations but Efficacy and Safety Largely Unknown.
Hussain Z, Khan JA
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Once-Daily Oral Semaglutide With, Without, or in Combination With Metformin in Patients With Type 2 Diabetes
Ahrén B, Masmiquelle C, Freyche S, et al.
Community updates
No updates yet for this supplement.
Be the first to share your experience!